Last updated on September 2018

A Safety and Tolerability Study of an Investigational Drug ALN-TTRSC02 in Healthy Subjects

Brief description of study

The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of ALN-TTRSC02 in healthy subjects.

Clinical Study Identifier: NCT02797847

Contact Investigators or Research Sites near you

Start Over

Clinical Trial Site
London, United Kingdom